rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Susan Molineaux

Director

Company insider

Files Form 4 as: Director, Geron; Director, Repare Therapeutics; Director, Cyteir Therapeutics; President & CEO, Calithera Biosciences; Director, Theravance Biopharma.

Every Form 4 they filed

In numbers

Trades disclosed
117
Buys
2
Sells
1
Bought
$285K
Sold
$87K
Companies
5
Companies where not an officer
4
First trade
26 Sep 2012
Last trade
20 May 2026
Last filed
26 May 2026

Companies traded

Where they are an officer
Calithera BiosciencesDirector, Officer · last 23 Jan 20232 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
GERN GeronDirector · Biotechnology · last 20 May 20260 buys · 1 sell
Repare TherapeuticsDirector · last 17 Jun 20240 buys · 0 sells
Cyteir TherapeuticsDirector · last 3 Feb 20230 buys · 0 sells
Theravance BiopharmaDirector · Pharmaceuticals · last 27 Apr 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 May 2026filed 26 May 2026GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—220,000 at $0.00filing
20 May 2026filed 26 May 2026GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—220,000 at $0.00filing
21 May 2025filed 22 May 2025GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—180,000 at $0.00filing
17 Jun 2024filed 20 Jun 2024Repare Therapeuticsoption or derivativeSEC FORM 4 Code A—27,200 at $0.00filing
9 May 2024filed 10 May 2024GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—180,000 at $0.00filing
29 Dec 2023filed 3 Jan 2024GERN GeronBiotechnologySEC FORM 4 Code A—6,220 at $0.00filing
29 Sep 2023filed 2 Oct 2023GERN GeronBiotechnologySEC FORM 4 Code A—6,191 at $0.00filing
30 Jun 2023filed 30 Jun 2023GERN GeronBiotechnologySEC FORM 4 Code A—4,088 at $0.00filing
8 Jun 2023filed 12 Jun 2023Repare Therapeuticsoption or derivativeSEC FORM 4 Code A—76,200 at $0.00filing
31 May 2023filed 2 Jun 2023GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
1 May 2023filed 1 May 2023GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code M—35,000 at $0.00filing
1 May 2023filed 1 May 2023GERN GeronBiotechnologySEC FORM 4 Code M$39K35,000 at $1.10filing
1 May 2023filed 1 May 2023GERN GeronBiotechnologySEC FORM 4 Sold$87K35,000 at $2.48filing
31 Mar 2023filed 3 Apr 2023GERN GeronBiotechnologySEC FORM 4 Code A—6,048 at $0.00filing
3 Feb 2023filed 7 Feb 2023Cyteir Therapeuticsoption or derivativeSEC FORM 4 Code A—14,150 at $0.00filing
23 Jan 2023filed 25 Jan 2023Calithera BiosciencesSEC FORM 4 Code F$237526 at $0.45filing
10 May 2022filed 11 May 2022GERN Geronoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
22 Feb 2022filed 24 Feb 2022Cyteir Therapeuticsoption or derivativeSEC FORM 4 Code A—14,150 at $0.00filing
25 Jan 2022filed 27 Jan 2022Calithera Biosciencesoption or derivativeSEC FORM 4 Code A—597,475 at $0.00filing
10 Nov 2021filed 10 Nov 2021Calithera BiosciencesSEC FORM 4 Bought$85K100,000 at $0.85filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.